Albuminuria-lowering effect of sodium-glucose cotransporter 2 inhibitors could be partly attributable to the attenuation of tubular damage in type 2 diabetic patients.
Katsuyuki YanagisawaAmi SotokawauchiYuri NishinoTakanori MatsuiNobuhiro TaharaSho-Ichi YamagishiPublished in: Diabetes/metabolism research and reviews (2020)
Keyphrases